Tim-3 Expression by Peripheral Natural Killer Cells and Natural Killer T Cells Increases in Patients with Lung Cancer - Reduction after Surgical Resection |
Xu, Li-Yun
(Cell and Molecular Biology Laboratory, Zhoushan Hospital)
Chen, Dong-Dong (Cell and Molecular Biology Laboratory, Zhoushan Hospital) He, Jian-Ying (Cell and Molecular Biology Laboratory, Zhoushan Hospital) Lu, Chang-Chang (Lung Cancer Research Center of Zhoushan, Zhoushan Hospital) Liu, Xiao-Guang (Cell and Molecular Biology Laboratory, Zhoushan Hospital) Le, Han-Bo (Department of Cardio-Thoracic Surgery, Zhoushan Hospital) Wang, Chao-Ye (Department of Cardio-Thoracic Surgery, Zhoushan Hospital) Zhang, Yong-Kui (Lung Cancer Research Center of Zhoushan, Zhoushan Hospital) |
1 | Anderson AC (2012). Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol, 24, 213-6. DOI |
2 | Chiba S, Baghdadi M, Akiba H, et al (2012). Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol, 13, 832-42. DOI |
3 | Da Silva IP, Gallois A, Jimenez-Baranda S, et al (2014). Reversal of NK- cell exhaustion in advanced melanoma by Tim-3 blockade. Cancer Immunol Res, 2, 410-22. DOI |
4 | Gleason MK, Lenvik TR, McCullar V, et al (2012). Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galetin-9. Blood, 119, 3064-72. DOI |
5 | Gao X, Zhu Y, Li G, et al (2012). Tim-3 expression characterizes regulatoy T cells in tumor tissues and is associated with lung cancer progression. PloS One, 7, 30676. DOI |
6 | Hasegawa H, Yamashita K, Otubo D, et al (2014). Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activation. Anticancer Res, 34, 3411-7. |
7 | Hodge G, Barnawi J, Jursevic, C, et al (2014). Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)- by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells. Clin Exp Immunol, 178, 79-85. DOI |
8 | Ju Y, Hou N, Meng J, et al (2010). T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol, 52, 322-9. DOI |
9 | Liu Y, Shu Q, Gao L, et al (2010). Increased Tim-3 xpression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol, 137, 288-95. DOI ScienceOn |
10 | Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5. 과학기술학회마을 DOI ScienceOn |
11 | Wang WJ, Tao Z, Gu W, et al (2013). Variation of blood T lymphocyte subgroups in patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4671-3. 과학기술학회마을 DOI ScienceOn |
12 | Lu YY, Huang XE, Xu L, et al (2013). Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs. Asian Pac J Cancer Prev, 14, 2005-8. 과학기술학회마을 DOI ScienceOn |
13 | Meggyes M, Miko E, Polgar B, et al (2014). Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy. PloS One, 9, 92371. DOI |
14 | Ndhlovu LC, Lopez-Verges S, et al (2012). Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood, 119, 3734-43. DOI |
15 | Wu W, Shi Y, Li S, Zhang Y, et al (2012). Blockade of Tim-3 signaling restores the virus-specific CD8+ T cell response in patients with chronic hepatitis B. Eur J Immunol, 42, 1180-91. DOI |
16 | Yang X, Jiang X, Chen G, et al (2013). T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol, 190, 2068-79. DOI |